This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Queen's University directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study
Journal of Medical Internet Research · 2026
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study
Journal of Medical Internet Research · 2025
Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets
JCO clinical cancer informatics · 2023
Latest funding
- $1,197,227
RATIONAL (Role of Antibiotic Therapy or Immunoglobulin On iNfection in hAematoLogy) Platform Trial: An RCT of continuing immunoglobulin therapy, or stopping with or without prophylactic antibiotics, on infection rate in patients with acquired hypogammaglobulinemia secondary to haematological malignancies
CIHR · 2024 · Co-investigator
- $3,056,172
A Phase III Non-Inferiority Randomized Controlled Trial (RCT) of Fixed-Duration Daratumumab Versus Continuous Daratumumab Among Transplant Ineligible Older Adults with Newly-Diagnosed Multiple Myeloma
CIHR · 2023 · Co-investigator
- $1,786,273
Fecal microbiota transplantation in combination with immune checkpoint blockade in patients with advanced melanoma: A randomized phase II trial
CIHR · 2023 · Co-investigator
7 publications.
Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study
Pilgram L, Yang K, Beltran-Bless A-A, Pond GR, Vandermeer L, Hilton J, Savard M-F, LeBlanc A, Shepherd L, Chen B
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study
Kababji SE, Mitsakakis N, Jonker E, Beltran-Bless A-A, Pond G, Vandermeer L, Radhakrishnan D, Mosquera L, Paterson A, Shepherd L
Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets
Kababji SE, Mitsakakis N, Fang X, Beltran-Bless A-A, Pond G, Vandermeer L, Radhakrishnan D, Mosquera L, Paterson A, Shepherd L
Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies.
Hilton J, Gelmon K, Bedard PL, Tu D, Xu H, Tinker AV, Goodwin R, Laurie SA, Jonker D, Hansen AR, Veitch ZW, Renouf DJ, Hagerman L, Lui H, Chen B, Kellar D, Li I, Lee SE, Kono T, Cheng BYC, Yap D, Lai D, Beatty S, Soong J, Pritchard KI, Soria-Bretones I, Chen E, Feilotter H, Rushton M, Seymour L, Aparicio S, Cescon DW
Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27.
Niravath P, Chen B, Chapman JW, Agarwal SK, Welschhans RL, Bongartz T, Kalari KR, Shepherd LE, Bartlett J, Pritchard K, Gelmon K, Hilsenbeck SG, Rimawi MF, Osborne CK, Goss PE, Ingle JN
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Liu S, Chen B, Burugu S, Leung S, Gao D, Virk S, Kos Z, Parulekar WR, Shepherd L, Gelmon KA, Nielsen TO
Inference on treatment-covariate interaction based on a nonparametric measure of treatment effects and censored survival data.
Jiang S, Chen B, Tu D
RATIONAL (Role of Antibiotic Therapy or Immunoglobulin On iNfection in hAematoLogy) Platform Trial: An RCT of continuing immunoglobulin therapy, or stopping with or without prophylactic antibiotics, on infection rate in patients with acquired hypogammaglobulinemia secondary to haematological malignancies
Principal investigators: Callum, Jeannie L; Reiman, Tony
Keywords: Adaptive Platform Trial; Antibiotic Therapy; Hematologic Malignancies; Hypogammaglobulinemia; Immunoglobulin; Infections
A Phase III Non-Inferiority Randomized Controlled Trial (RCT) of Fixed-Duration Daratumumab Versus Continuous Daratumumab Among Transplant Ineligible Older Adults with Newly-Diagnosed Multiple Myeloma
Principal investigators: Hay, Annette; Mian, Hira
Keywords: De-Escalation; Economic Analysis; Multiple Myeloma; Quality Of Life; Randomized Phase Iii Trial
Fecal microbiota transplantation in combination with immune checkpoint blockade in patients with advanced melanoma: A randomized phase II trial
Principal investigators: Dancey, Janet E; Elkrief, Arielle; Lenehan, John; Maleki, Saman; Routy, Bertrand; Silverman, Michael
Keywords: Fecal Microbiota Transplant; Melanoma; Microbiome; Multicentre; Phase Ii; Progression-Free Survival; Randomized Controlled Trial
Randomized Phase 3 Evaluation of Lower Dose (3-2-1 Strategy) vs. Full Dose of Ibrutinib for the Treatment of Chronic Lymphocytic Leukemia
Principal investigators: Hay, Annette; Cheung, Matthew C
Keywords: Chronic Lymphocytic Leukemia; Economics; Non-Inferiority; Quality Of Life; Randomized Controlled Trial; Toxicity
SPECT-CT Guided ELEctive Contralateral Neck Treatment (SELECT) for Patients with Lateralized Oropharyngeal Cancer: A Phase III Randomized Controlled Trial
Principal investigators: Parulekar, Wendy R; de Almeida, John R; Hosni Abdalaty, Ali
Keywords: Cost Utility; De-Intestification; Image-Guided Treatment; Lymphatic Mapping; Oropharyngeal Cancer; Quality Of Life; Spect-Ct; Volume De-Intesification
Randomized Phase 3 Evaluation of Lower Dose (3-2-1 Strategy) vs. Full Dose of Ibrutinib for the Treatment of Chronic Lymphocytic Leukemia
Principal investigators: Hay, Annette; Cheung, Matthew C
Keywords: Chronic Lymphocytic Leukemia; De-Escalation; Non-Inferiority; Randomized Controlled Trial; Toxicity
Melanoma Margins Trial II - A Phase III, Multi-centre Randomized Controlled Trial Investigating 1cm v 2cm Wide Surgical Excision Margins for AJCC stage II Primary Cutaneous Melanoma (MelMarT-II)
Principal investigators: Dancey, Janet E; Wright, Frances C
Keywords: Cancer; Melanoma; Quality Of Life; Randomized Controlled Trial; Surgery; Surgical Morbidity / Complications; Wide Local Excision
Statistical infernce for survival data: nonparametric methods and deep learning
Principal investigators: Chen, Bingshu
Keywords: survival analysis; accelerated failure time model; cox proportional hazards model; non-parametric methods; local linear partial likelihood; biomarker-treatment interaction; deep learning neural networks; expectation-maximization (em) algorithm
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
Principal investigators: Parulekar, Wendy R; Bratman, Scott V
Keywords: Cooperative Group; De-Escalation; Head And Neck Cancer; Human Papillomavirus; Multi-Institutional; Oropharynx Cancer; Phase Ii Clinical Study; Radiotherapy
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
Principal investigators: Parulekar, Wendy R; Bratman, Scott V
Keywords: Cooperative Group; De-Escalation; Head And Neck Cancer; Human Papillomavirus; Multi-Institutional; Oropharynx Cancer; Phase Ii Clinical Study; Radiotherapy
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Gregory Pond and Mark Clemons: 47 shared papers
- Mark Clemons and John Hilton: 41 shared papers
- Gregory Pond and John Hilton: 22 shared papers
- Mark Clemons and Marie-France Savard: 20 shared papers
- Lesley Seymour and Dongsheng Tu: 20 shared papers
- Gregory Pond and Marie-France Savard: 11 shared papers
- Marie-France Savard and John Hilton: 9 shared papers
- Derek Jonker and Dongsheng Tu: 8 shared papers
- Gregory Pond and Khaled El Emam: 6 shared papers
- Mark Clemons and Khaled El Emam: 6 shared papers
- Khaled El Emam and Marie-France Savard: 5 shared papers
- Gregory Pond and Melanie Spears: 3 shared papers
- Gregory Pond and Bingshu Chen: 3 shared papers
- Mark Clemons and Melanie Spears: 3 shared papers
- Mark Clemons and Bingshu Chen: 3 shared papers
- Dhenuka Radhakrishnan and Khaled El Emam: 3 shared papers
- Khaled El Emam and Bingshu Chen: 3 shared papers
- Lesley Seymour and John Hilton: 3 shared papers
- Marie-France Savard and Bingshu Chen: 3 shared papers
- John Hilton and Dongsheng Tu: 3 shared papers
- Gregory Pond and Dhenuka Radhakrishnan: 2 shared papers
- Gregory Pond and Zuzana Kos: 2 shared papers
- Samuel Aparicio and Lesley Seymour: 2 shared papers
- Samuel Aparicio and John Hilton: 2 shared papers
- Mark Clemons and Dhenuka Radhakrishnan: 2 shared papers
- Mark Clemons and Zuzana Kos: 2 shared papers
- Dhenuka Radhakrishnan and Bingshu Chen: 2 shared papers
- Lesley Seymour and Derek Jonker: 2 shared papers
- Derek Jonker and John Hilton: 2 shared papers
- John Hilton and Zuzana Kos: 2 shared papers
- John Hilton and Melanie Spears: 2 shared papers
- John Hilton and Bingshu Chen: 2 shared papers
- Samuel Aparicio and Derek Jonker: 1 shared paper
- Samuel Aparicio and Bingshu Chen: 1 shared paper
- Lesley Seymour and Bingshu Chen: 1 shared paper
- Derek Jonker and Bingshu Chen: 1 shared paper
- Zuzana Kos and Bingshu Chen: 1 shared paper
- Melanie Spears and Bingshu Chen: 1 shared paper
- Dongsheng Tu and Bingshu Chen: 1 shared paper
- Public Health Sciences
- Department of Medicine
- Oncology
- Pediatrics
- Clinical Epidemiology
- Department of Laboratory Medicine and Pathobiology
- Molecular Oncology
- Other
Co-authors at Queen's University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Gregory Pond
Oncology
3 shared papers, latest 2026
Mark Clemons
Clinical Epidemiology
3 shared papers, latest 2026
Khaled El Emam
Pediatrics
3 shared papers, latest 2026
Marie-France Savard
Faculty
3 shared papers, latest 2026
Dhenuka Radhakrishnan
Faculty
2 shared papers, latest 2025
John Hilton
Department of Medicine
2 shared papers, latest 2026
Dongsheng Tu
Public Health Sciences
1 shared papers, latest 2022
Derek Jonker
Department of Medicine
1 shared papers, latest 2022
Melanie Spears
Department of Laboratory Medicine and Pathobiology
1 shared papers, latest 2026
Samuel Aparicio
Molecular Oncology
1 shared papers, latest 2022
Zuzana Kos
Pathology and Laboratory Medicine
1 shared papers, latest 2017
Lesley Seymour
Faculty
1 shared papers, latest 2022
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.